Loading clinical trials...
Loading clinical trials...
Assessment of Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions
Interventions
POT-4
Locations
6
United States
United States, Arizona
Tucson, Arizona, United States
United States, California
Beverly Hills, California, United States
United States, Florida
Gainesville, Florida, United States
United States, Florida
Miami, Florida, United States
United States, Minnesota
Rochester, Minnesota, United States
United States, New Hampshire
Portsmouth, New Hampshire, United States
Start Date
May 1, 2007
Primary Completion Date
February 1, 2010
Completion Date
February 1, 2010
Last Updated
March 18, 2010
NCT05913063
NCT06990269
NCT06970665
NCT07160179
NCT06557460
NCT05562947
Lead Sponsor
Potentia Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions